Single-center study results of cefotetan and cefoxitin prophylaxis for abdominal or vaginal hysterectomy.
A prospective randomized study of 90 patients undergoing hysterectomy who received a single 1 gm dose of cefotetan and multiple 2 gm doses of cefoxitin was completed. An overall infection rate of 1.2% was recorded. Bacteriologic and clinical success rates were not different between antibiotics.
D000005:Abdomen; D000328:Adult; D000368:Aged; D015313:Cefotetan; D002440:Cefoxitin / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007045:Hysterectomy, Vaginal; D017053:Infection Control; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D011897:Random Allocation; D013530:Surgical Wound Infection / Q000517:prevention & control
D002513:Cephamycins; D015313:Cefotetan; D002440:Cefoxitin